Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2014, Article ID 234941, 6 pages
http://dx.doi.org/10.1155/2014/234941
Research Article

Drugs Cheaper Than Threepenny: The Market of Extremely Low-Priced Drugs within the National Health Insurance in Taiwan

1Department of Pharmacy, Taipei Veterans General Hospital, Taipei 11217, Taiwan
2Institute of Pharmacology, School of Medicine, National Yang-Ming University, Taipei 11217, Taiwan
3College of Pharmacy, Taipei Medical University, Taipei 11031, Taiwan
4Department of Family Medicine, Taipei Veterans General Hospital, Taipei 11217, Taiwan
5Institute of Hospital and Health Care Administration, School of Medicine, National Yang-Ming University, Taipei 11217, Taiwan
6Department of Public Finance, National Chengchi University, Taipei 11605, Taiwan

Received 13 November 2013; Accepted 13 January 2014; Published 25 February 2014

Academic Editors: P. Laurenti and S. Leng

Copyright © 2014 Bih-Ru Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. M. Ess, S. Schneeweiss, and T. D. Szucs, “European healthcare policies for controlling drug expenditure,” PharmacoEconomics, vol. 21, no. 2, pp. 89–103, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. D. Menon, “Pharmaceutical cost control in Canada: does it work?” Health Affairs, vol. 20, no. 3, pp. 92–103, 2001. View at Google Scholar · View at Scopus
  3. A. Cameron, M. Ewen, D. Ross-Degnan, D. Ball, and R. Laing, “Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis,” The Lancet, vol. 373, no. 9659, pp. 240–249, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. Bureau of National Health Insurance, Department of Health, Executive Yuan, “Universal Health Coverage in Taiwan,” http://www.nhi.gov.tw/Resource/webdata/21717_1_20120808UniversalHealthCoverage.pdf.
  5. Y.-C. Lee, M.-C. Yang, Y.-T. Huang, C.-H. Liu, and S.-B. Chen, “Impacts of cost containment strategies on pharmaceutical expenditures of the National Health Insurance in Taiwan, 1996–2003,” PharmacoEconomics, vol. 24, no. 9, pp. 891–902, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. National Health Research Institutes, “National Health Insurance Research Database,” http://w3.nhri.org.tw/nhird/en/index.htm.
  7. Y.-C. Chen, H.-Y. Yeh, J.-C. Wu, I. Haschler, T.-J. Chen, and T. Wetter, “Taiwan's National Health Insurance Research Database: administrative health care database as study object in bibliometrics,” Scientometrics, vol. 86, no. 2, pp. 365–380, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. Bureau of National Health Insurance, “Department of Health, Executive Yuan,” The National Health Insurance Statistics, 2007, http://www.nhi.gov.tw/English/webdata/webdata.aspx?menu=11&menu_id=296&WD_ID=296&webdata_id=2329.
  9. J. S. Haas, K. A. Phillips, E. P. Gerstenberger, and A. C. Seger, “Potential savings from substituting generic drugs for brand-name drugs: medical expenditure panel survey, 1997–2000,” Annals of Internal Medicine, vol. 142, no. 11, pp. 891–897, 2005. View at Google Scholar · View at Scopus
  10. J. N. Liberman and M. C. Roebuck, “Prescription drug costs and the generic dispensing ratio,” Journal of Managed Care Pharmacy, vol. 16, no. 7, pp. 502–506, 2010. View at Google Scholar · View at Scopus
  11. C.-L. Chen, L. Chen, and W.-C. Yang, “The influences of Taiwan's generic grouping price policy on drug prices and expenditures: evidence from analysing the consumption of the three most-used classes of cardiovascular drugs,” BMC Public Health, vol. 8, article 118, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. A. S. Kesselheim and N. K. Choudhry, “The international pharmaceutical market as a source of low-cost prescription drugs for U.S. patients,” Annals of Internal Medicine, vol. 148, no. 8, pp. 614–619, 2008. View at Google Scholar · View at Scopus
  13. S. Merkur and E. Mossialos, “A pricing policy towards the sourcing of cheaper drugs in Cyprus,” Health Policy, vol. 81, no. 2-3, pp. 368–375, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. World Health Organization, Health Action International, “Medicine prices-A new approach to measurement,” Geneva, Switzerland, 2003, http://whqlibdoc.who.int/hq/2003/WHO_EDM_PAR_2003.2.pdf.
  15. World Health Organization, Health Action International, Measuring Medicine Prices, Avialability, Affordability and Price Components, Geneva, Switzerland, 2nd edition, 2008, http://apps.who.int/medicinedocs/index/assoc/s14868e/s14868e.pdf.
  16. Y.-M. Liu, Y.-H. K. Yang, and C.-R. Hsieh, “Regulation and competition in the Taiwanese pharmaceutical market under national health insurance,” Journal of Health Economics, vol. 31, no. 3, pp. 471–483, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. Bureau of National Health Insurance, “Department of Health, Executive Yuan, “ General Principles,” http://www.nhi.gov.tw/English/webdata/webdata.aspx?menu=11&menu_id=295&WD_ID=295&webdata_id=2441.
  18. Bureau of National Health Insurance, “Department of Health, Executive Yuan, ” Guidelines of price adjustment for National Health Insurance reimbursed drugs,” http://www.nhi.gov.tw/English/webdata/webdata.aspx?menu=11&menu_id=295&WD_ID=295&webdata_id=2444.
  19. Bureau of National Health Insurance, “Department of Health, Executive Yuan, " The National Health Insurance Statistics,” 2008, http://www.nhi.gov.tw/English/webdata/webdata.aspx?menu=11&menu_id=296&WD_ID=296&webdata_id=3109.